Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2019-01-03 2019-01-03
Drug Identification Number 02376598 02376598
Brand name IBUPROFEN LIQUID GEL CAPSULES IBUPROFEN LIQUID GEL CAPSULES
Common or Proper name IBUPROFEN CAP 200MG IBUPROFEN CAP 200MG
Company Name APOTEX INC APOTEX INC
Ingredients IBUPROFEN IBUPROFEN
Strength(s) 200MG 200MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 16 BTL & 32 BTL 16 BTL & 32 BTL
ATC code M01AE M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2018-01-03 2018-01-03
Remaining supply date 2018-01-03 2018-01-03
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments